COSMO Pharmaceuticals N.V.
COPN | SW
Overview
Corporate Details
- ISIN(s):
- NL0011832936
- LEI:
- 724500OX0EBQRYTVV639
- Country:
- Netherlands (Kingdom of the)
- Address:
- Sir Rogerson's Quay Riverside II, Dublin 2 Dublin
- Website:
- https://www.cosmopharma.com/
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
COSMO Pharmaceuticals N.V. is a specialty pharmaceutical company focusing on innovative therapies for gastrointestinal diseases and specialty treatments.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
Market Cap data is planned for a future update.
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-07-01 02:00 |
Investor Presentation
Cosmo Unveils Bold 2030 Vision and Strategy; launches AI-driven Growth Phase at…
|
English | 8.4 KB | |
| 2025-07-01 02:00 |
Investor Presentation
Cosmo präsentiert mutige Vision und Strategie für 2030 und leitet am Investoren…
|
German | 9.5 KB | |
| 2025-06-25 02:00 |
Regulatory News Service
Cosmo Announces Sale of “Digital Trust” in Strategic Portfolio Streamlining Move
|
English | 6.8 KB | |
| 2025-06-25 02:00 |
Regulatory News Service
Cosmo gibt Verkauf von «Digital Trust» im Rahmen einer strategischen Portfolio-…
|
German | 7.4 KB | |
| 2025-06-24 02:00 |
Regulatory News Service
Cosmo to Unveil First-of-its-Kind Clinical Study on the Use of GI Genius™ with …
|
English | 8.7 KB | |
| 2025-06-24 02:00 |
Regulatory News Service
Cosmo führt erste klinische Studie zur Verwendung von GI Genius™ mit Apple Visi…
|
German | 9.7 KB | |
| 2025-05-30 02:00 |
Declaration of Voting Results & Voting Rights Announcements
Voting results of Cosmo’s 2025 AGM
|
English | 5.1 KB | |
| 2025-05-30 02:00 |
Declaration of Voting Results & Voting Rights Announcements
Ergebnisse der Generalversammlung 2025 von Cosmo
|
German | 5.4 KB | |
| 2025-05-05 02:00 |
Regulatory News Service
Cosmo Highlights Strategic AI and GI Innovation Agenda at Digestive Disease Wee…
|
English | 6.4 KB | |
| 2025-05-05 02:00 |
Regulatory News Service
Cosmo präsentiert strategische Innovationsagenda für KI und Gastroenterologie a…
|
German | 7.1 KB | |
| 2025-05-02 02:00 |
Regulatory News Service
Cosmo Announces EU MDR Certification for Endovision’s Cerebro, expanding its re…
|
English | 10.3 KB | |
| 2025-05-02 02:00 |
Regulatory News Service
Cosmo gibt EU-MDR-Zertifizierung für Cerebro von Endovision bekannt und erweite…
|
German | 11.4 KB | |
| 2025-04-01 02:00 |
Board/Management Change
Cosmo appoints Federico Sommariva as Chief Legal Counsel
|
English | 5.2 KB | |
| 2025-04-01 02:00 |
Board/Management Change
Cosmo ernennt Federico Sommariva zum Chief Legal Counsel
|
German | 5.9 KB | |
| 2025-03-06 01:00 |
Earnings Release
Cosmo Pharmaceuticals Delivers Record 2024 Results – Completes Phase III Enroll…
|
English | 28.1 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
ABIVAX | France | ABVX | |
|
Addex Therapeutics Ltd | Switzerland | ADXN | |
|
AegirBio AB | Sweden | AEGIR | |
|
AGRONOMICS LIMITED | Isle of Man | ANIC | |
|
AIREA PLC | United Kingdom | AIEA | |
|
Alkaloid AD | North Macedonia | ALK | |
| Alma Yesodot Ltd. | Israel | KVSR | ||
|
Amphastar Pharmaceuticals Inc. | United States of America | AMPH | |
| Ananda Pharma Plc | United Kingdom | N/A | ||
|
Antibiotice S.A. | Romania | ATB |